Jeff is a preclinical research and development scientist with more than 35 years’ experience in the conduct of pharmacology and toxicology studies. His primary area of expertise is in inhalation toxicology and respiratory pharmacology with over 60 peer reviewed publications in the field. He obtained his PhD in Pharmacology and Toxicology from the University of Rochester and is board-certified in both toxicology and safety pharmacology. He previously worked as a Project Scientist on contract to the US EPA Inhalation Toxicology Division, a Senior Scientist at Genentech in the Pulmonary and Immunology group, the Director of Pharmacology at Bayer Biotechnology, VP of Pharmacology/Toxicology at Catalyst Biosciences and helped establish and headed Pharmacology/Toxicology at Aerovance Inc., a respiratory biotech company. Since 2007, Jeff has worked as an independent Pharm/Tox consultant supporting virtual to multi-national companies developing biopharmaceuticals.